Invex Therapeutics Ltd (ASX:IXC)
Australia · Delayed Price · Currency is AUD 0.1200
-0.0050 (-4.00%)
Mar 4, 2026, 3:31 PM AEST
Invex Therapeutics Market Cap
Invex Therapeutics has a market cap or net worth of 9.39 million as of March 3, 2026. Its market cap has increased by 64.47% in one year.
Market Cap
9.39M
Enterprise Value
4.80M
Revenue
229.08K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 9.39M, a decrease of -84.11%. That is a compound annual growth rate of -24.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 9.39M | 4.17% |
| Dec 30, 2025 | 9.02M | 81.82% |
| Dec 23, 2024 | 4.96M | -18.52% |
| Dec 27, 2023 | 6.09M | -85.14% |
| Dec 28, 2022 | 40.96M | -22.70% |
| Dec 31, 2021 | 52.98M | -1.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurotech International | 16.85M |
| Tissue Repair | 10.88M |
| AdAlta | 10.20M |
| Bio-Gene Technology | 10.07M |
| Immuron | 9.11M |
| Chimeric Therapeutics | 8.84M |
| Biotron | 8.11M |
| Nexalis Therapeutics | 7.09M |